Analyst Ratings for The Medicines Company (MDCO)
MDCO Rating Summary
MDCO Price Target Summary
- Highest: $65.00 (Auriga)
- Lowest: $20.00 (Citadel Securities)
- Average: $35.75
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$35.75 (-0%)
Avg. $ Target:
$35.75 (-0%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/27/2013 | Guggenheim | New Coverage | Buy (N/A) |
39.00 (N/A) |
33.34 | 35.76 | 7.26% | Details |
| 3/15/2013 | Credit Suisse | New Coverage | Outperform (N/A) |
38.00 (N/A) |
31.95 | 35.76 | 11.92% | Details |
| 1/3/2013 | ISI Group | New Coverage | Buy (N/A) |
30.00 (N/A) |
24.54 | 35.76 | 45.72% | Details |
| 12/20/2012 | JPMorgan | Upgrade | Overweight (Neutral) |
32.00 (28.00) |
22.29 | 35.76 | 60.43% | Details |
| 11/20/2012 | Oppenheimer » Updated 1/9/2013 |
New Coverage | Outperform (N/A) |
35.00 (35.00) |
20.89 | 35.76 | 71.18% | Details |
| 10/16/2012 | Jefferies » Updated 4/25/2013 |
Upgrade | Buy (Hold) |
38.50 (36.00) |
23.98 | 35.76 | 49.12% | Details |
| 8/22/2012 | BofA/Merrill Lynch | New Coverage | Neutral (N/A) |
29.00 (N/A) |
25.08 | 35.76 | 42.58% | Details |
| 8/8/2012 | WallachBeth Capital | New Coverage | Buy (N/A) |
31.00 (N/A) |
25.16 | 35.76 | 42.13% | Details |
| 11/30/2011 | Auriga » Updated 4/26/2012 |
New Coverage | Buy (N/A) |
65.00 (N/A) |
18.31 | 35.76 | 95.3% | Details |
| 8/8/2011 | Citadel Securities | New Coverage | Add (N/A) |
20.00 (N/A) |
13.78 | 35.76 | 159.51% | Details |
| 6/9/2011 | Argus | Upgrade | Buy (N/A) |
N/A (N/A) |
17.37 | 35.76 | 105.87% | Details |
| 10/7/2010 | RBC Capital | Downgrade | Sector Perform (N/A) |
N/A (N/A) |
13.62 | 35.76 | 162.56% | Details |
| 8/4/2010 | Wedbush | Upgrade | Neutral (N/A) |
N/A (N/A) |
12.47 | 35.76 | 186.77% | Details |
